Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 19041351)

1.

Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.

Greengold B, Nyamathi A, Kominski G, Wiley D, Lewis MA, Hodge F, Singer M, Spiegel B.

Vaccine. 2009 Jan 29;27(5):718-25. doi: 10.1016/j.vaccine.2008.11.031. Epub 2008 Nov 27.

2.

Experience with hepatitis A and B vaccines.

Davis JP.

Am J Med. 2005 Oct;118 Suppl 10A:7S-15S. Review.

PMID:
16271535
3.

Combining hepatitis A and B vaccination in children and adolescents.

Van Damme P, Van der Wielen M.

Vaccine. 2001 Mar 21;19(17-19):2407-12. Review.

PMID:
11257370
4.

The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.

Keystone JS, Hershey JH.

Int J Infect Dis. 2008 Jan;12(1):3-11. Epub 2007 Jul 20. Review.

5.

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

Koff RS.

J Clin Gastroenterol. 2001 Jul;33(1):20-6. Review.

PMID:
11418785
6.

Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers.

Nothdurft HD, Zuckerman J, Stoffel M, Dieussaert I, Van Damme P.

J Travel Med. 2004 Jul-Aug;11(4):260-1. Review. No abstract available.

PMID:
15541232
7.

The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.

Oldfield EC 3rd, Keeffe EB.

Rev Gastroenterol Disord. 2007 Winter;7(1):1-21. Review.

PMID:
17392626
8.

[Viral hepatitis: preventable illnesses].

Baumgarten R.

Z Arztl Fortbild Qualitatssich. 1998 Dec;92(10):677-80. Review. German.

PMID:
10028595
9.

Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Irving GJ, Holden J, Yang R, Pope D.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD009051. doi: 10.1002/14651858.CD009051.pub2. Review.

PMID:
22786522
10.

Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.

Beran J.

Expert Rev Vaccines. 2007 Dec;6(6):891-902. doi: 10.1586/14760584.6.6.891. Review.

PMID:
18377352
11.

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.

Van Damme P, Van Herck K.

Expert Rev Vaccines. 2004 Jun;3(3):249-67. Review.

PMID:
15176942
12.

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.

Beutels P, Edmunds WJ, Antoñanzas F, De Wit GA, Evans D, Feilden R, Fendrick AM, Ginsberg GM, Glick HA, Mast E, Péchevis M, Van Doorslaer EK, van Hout BA; Viral Hepatitis Prevention Board.

Pharmacoeconomics. 2002;20(1):1-7. Review.

PMID:
11817988
13.

The place of accelerated schedules for hepatitis A and B vaccinations.

Zuckerman J.

Drugs. 2003;63(17):1779-84. Review.

PMID:
12921484
14.

[Combined vaccine against hepatitis A and B].

Pawłowska M, Halota W, Kozielewicz D.

Przegl Epidemiol. 2004;58 Suppl 1:66-70. Review. Polish.

PMID:
15807160
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk